{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T21:47:53Z","timestamp":1715982473374},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.beha.2011.02.005","type":"journal-article","created":{"date-parts":[[2011,5,7]],"date-time":"2011-05-07T22:48:25Z","timestamp":1304808505000},"page":"165-177","source":"Crossref","is-referenced-by-count":12,"title":["Imaging in follicular NHL"],"prefix":"10.1016","volume":"24","author":[{"given":"M.S.","family":"Hofman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.J.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.beha.2011.02.005_bib1","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/0277-5379(91)90280-Q","article-title":"Follicular dendritic cells in non-Hodgkin lymphomas: localisation, characterisation and pathophysiological aspects","volume":"27","author":"Petrasch","year":"1991","journal-title":"Eur J Cancer"},{"issue":"23","key":"10.1016\/j.beha.2011.02.005_bib2","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM198412063112303","article-title":"The natural history of initially untreated low-grade non-Hodgkin\u2019s lymphomas","volume":"311","author":"Horning","year":"1984","journal-title":"N Engl J Med Dec 6"},{"issue":"5","key":"10.1016\/j.beha.2011.02.005_bib3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/CCO.0b013e3282c9ad78","article-title":"Natural history of follicular grade 3 non-Hodgkin\u2019s lymphoma","volume":"19","author":"Bierman","year":"2007","journal-title":"Curr Opin Oncol"},{"issue":"Suppl. 5","key":"10.1016\/j.beha.2011.02.005_bib4","doi-asserted-by":"crossref","first-page":"v181","DOI":"10.1093\/annonc\/mdq184","article-title":"Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Dreyling","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beha.2011.02.005_bib5","series-title":"Practice guidelines in oncology v.1.2010: non-Hodgkin\u2019s Lymphomas","year":"2010"},{"issue":"5","key":"10.1016\/j.beha.2011.02.005_bib6","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-Celigny","year":"2004","journal-title":"Blood Sep 1"},{"issue":"27","key":"10.1016\/j.beha.2011.02.005_bib7","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","article-title":"Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project","volume":"27","author":"Federico","year":"2009","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.beha.2011.02.005_bib8","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.beha.2011.02.005_bib9","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: Cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2011.02.005_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/asheducation-2007.1.216","article-title":"Clinical features, prognosis and treatment of follicular lymphoma","author":"Salles","year":"2007","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"7","key":"10.1016\/j.beha.2011.02.005_bib11","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/jama.212.7.1182","article-title":"Scanning malignant neoplasms with gallium 67","volume":"212","author":"Edwards","year":"1970","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.beha.2011.02.005_bib12","first-page":"40","article-title":"67Ga scintigraphy in B-cell non-Hodgkin\u2019s lymphoma: correlation of 67Ga uptake with histology and transferrin receptor expression","volume":"40","author":"Nejmeddine","year":"1999","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.beha.2011.02.005_bib13","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1200\/JCO.1996.14.6.1936","article-title":"Utility of gallium-67 scintigraphy in low-grade non-Hodgkin\u2019s lymphoma","volume":"14","author":"Ben-Haim","year":"1996","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.beha.2011.02.005_bib14","first-page":"404","article-title":"67Ga-citrate imaging in untreated malignant lymphoma: preliminary report of Cooperative Group","volume":"15","author":"Greenlaw","year":"1974","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.beha.2011.02.005_bib15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00259-008-0958-z","article-title":"Positron emission tomography changes management, improves prognostic stratification and is superior to gallium scintigraphy in patients with low-grade lymphoma: results of a multicentre prospective study","volume":"36","author":"Scott","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.beha.2011.02.005_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3816\/CLM.2003.n.013","article-title":"Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin\u2019s lymphoma","volume":"4","author":"Blum","year":"2003","journal-title":"Clin Lymphoma"},{"issue":"6","key":"10.1016\/j.beha.2011.02.005_bib17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1023\/A:1011169332265","article-title":"Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin\u2019s lymphoma (NHL)","volume":"12","author":"Jerusalem","year":"2001","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.beha.2011.02.005_bib18","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/annonc\/mdl014","article-title":"18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading","volume":"17","author":"Wohrer","year":"2006","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.beha.2011.02.005_bib19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3816\/CLM.2008.n.040","article-title":"Value of [18F]fluorodeoxyglucose positron emission tomography in the management of follicular lymphoma: the end of a dilemma?","volume":"8","author":"Janikova","year":"2008","journal-title":"Clin Lymphoma Myeloma"},{"issue":"10","key":"10.1016\/j.beha.2011.02.005_bib20","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.2967\/jnumed.109.064121","article-title":"Observer variation in interpreting 18F-FDG PET\/CT findings for lymphoma staging","volume":"50","author":"Hofman","year":"2009","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.beha.2011.02.005_bib21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1148\/radiol.2323030985","article-title":"Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging\u2013do we need contrast-enhanced CT?","volume":"232","author":"Schaefer","year":"2004","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.beha.2011.02.005_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/mdj024","article-title":"Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET\/CT era?","volume":"17","author":"Raanani","year":"2006","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.beha.2011.02.005_bib23","first-page":"1643","article-title":"PET\/CT in lymphoma: prospective study of enhanced full-dose PET\/CT versus unenhanced low-dose PET\/CT","volume":"47","author":"Rodriguez-Vigil","year":"2006","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.beha.2011.02.005_bib24","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijrobp.2005.08.010","article-title":"Long-term outcome and mortality trends in early-stage, grade 1-2 follicular lymphoma treated with radiation therapy","volume":"64","author":"Guadagnolo","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5\u20136","key":"10.1016\/j.beha.2011.02.005_bib25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/02841860310014435","article-title":"A systematic overview of radiation therapy effects in non-Hodgkin\u2019s lymphoma","volume":"42","author":"Gustavsson","year":"2003","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.beha.2011.02.005_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijrobp.2007.09.051","article-title":"Impact of [18f] fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-hodgkin lymphoma","volume":"71","author":"Wirth","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys May 1"},{"issue":"7","key":"10.1016\/j.beha.2011.02.005_bib27","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.5858\/2007-131-1084-GOFLCO","article-title":"Grading of follicular lymphoma: comparison of routine histology with immunohistochemistry","volume":"131","author":"Martinez","year":"2007","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.beha.2011.02.005_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.1985.3.1.25","article-title":"Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies","volume":"3","author":"Metter","year":"1985","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.beha.2011.02.005_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/10428190903494331","article-title":"Using positron emission tomography to assess tumor proliferation in non-Hodgkin lymphoma","volume":"51","author":"Hofman","year":"2010","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"10.1016\/j.beha.2011.02.005_bib30","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1182\/blood.V86.9.3522.bloodjournal8693522","article-title":"Increased glucose metabolism in untreated non-Hodgkin\u2019s lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose","volume":"86","author":"Lapela","year":"1995","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2011.02.005_bib31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s11307-009-0226-z","article-title":"Correlating metabolic activity with cellular proliferation in follicular lymphomas","volume":"11","author":"Tang","year":"2009","journal-title":"Mol Imaging Biol"},{"issue":"2","key":"10.1016\/j.beha.2011.02.005_bib32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/10428190903440953","article-title":"SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma","volume":"51","author":"Watanabe","year":"2010","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.beha.2011.02.005_bib33","first-page":"325","article-title":"Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity","volume":"33","author":"Okada","year":"1992","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.beha.2011.02.005_bib34","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MNM.0b013e3282f813a4","article-title":"Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET","volume":"29","author":"Berkowitz","year":"2008","journal-title":"Nucl Med Commun"},{"issue":"4","key":"10.1016\/j.beha.2011.02.005_bib35","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/10428190701262059","article-title":"The SUV and FLT PET: a tasty alphabet soup or a dog\u2019s breakfast?","volume":"48","author":"Hicks","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"22","key":"10.1016\/j.beha.2011.02.005_bib36","doi-asserted-by":"crossref","first-page":"11055","DOI":"10.1158\/0008-5472.CAN-06-1955","article-title":"Molecular imaging of proliferation in malignant lymphoma","volume":"66","author":"Buck","year":"2006","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.beha.2011.02.005_bib37","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1182\/blood-2002-09-2778","article-title":"Utility of FDG-PET scanning in lymphoma by WHO classification","volume":"101","author":"Elstrom","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2011.02.005_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.mnm.0000185000.81203.49","article-title":"Can [18F]fluorodeoxyglucose positron emission tomography imaging complement biopsy results from the iliac crest for the detection of bone marrow involvement in patients with malignant lymphoma?","volume":"27","author":"Fuster","year":"2006","journal-title":"Nucl Med Commun"},{"issue":"3","key":"10.1016\/j.beha.2011.02.005_bib39","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ejrad.2007.08.017","article-title":"Nodal status of malignant lymphoma in pelvic and retroperitoneal lymphatic pathways: comparison of integrated PET\/CT with or without contrast enhancement","volume":"67","author":"Morimoto","year":"2008","journal-title":"Eur J Radiol"},{"issue":"3","key":"10.1016\/j.beha.2011.02.005_bib40","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/1097-0142(19830801)52:3<393::AID-CNCR2820520302>3.0.CO;2-M","article-title":"An autopsy study of histologic progression in non-Hodgkin\u2019s lymphomas. 192 cases from the National Cancer Institute","volume":"52","author":"Garvin","year":"1983","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.beha.2011.02.005_bib41","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/annonc\/mdl162","article-title":"The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma","volume":"17","author":"Gine","year":"2006","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.beha.2011.02.005_bib42","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1200\/JCO.1995.13.7.1726","article-title":"Long-term survival after histologic transformation of low-grade follicular lymphoma","volume":"13","author":"Yuen","year":"1995","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.beha.2011.02.005_bib43","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1200\/JCO.2005.12.072","article-title":"Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin\u2019s lymphoma","volume":"23","author":"Schoder","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.beha.2011.02.005_bib44","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ajh.21406","article-title":"Role and prognostic significance of the Ki-67 index in non-Hodgkin\u2019s lymphoma","volume":"84","author":"Broyde","year":"2009","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.beha.2011.02.005_bib45","first-page":"1790","article-title":"Predicting malignancy grade with PET in non-Hodgkin\u2019s lymphoma","volume":"36","author":"Rodriguez","year":"1995","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.beha.2011.02.005_bib46","first-page":"1659","article-title":"Glucose-normalized standardized uptake value from (18)F-FDG PET in classifying lymphomas","volume":"46","author":"Wong","year":"2005","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.beha.2011.02.005_bib47","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3324\/haematol.12013","article-title":"Investigation of FDG-PET\/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma","volume":"93","author":"Bodet-Milin","year":"2008","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.beha.2011.02.005_bib48","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.beha.2011.02.005_bib49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/cncr.21967","article-title":"Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas","volume":"107","author":"Karam","year":"2006","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.beha.2011.02.005_bib50","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3816\/CLM.2007.n.005","article-title":"Predictive role of positron emission tomography in the outcome of patients with follicular lymphoma","volume":"7","author":"Zinzani","year":"2007","journal-title":"Clin Lymphoma Myeloma"},{"issue":"8","key":"10.1016\/j.beha.2011.02.005_bib51","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1080\/10428190701422059","article-title":"Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma","volume":"48","author":"Bishu","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.beha.2011.02.005_bib52","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1200\/JCO.2006.08.2305","article-title":"Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma","volume":"25","author":"Juweid","year":"2007","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.beha.2011.02.005_bib53","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1007\/s00259-010-1490-5","article-title":"Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma","volume":"37","author":"Barrington","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.beha.2011.02.005_bib54","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdq024","article-title":"FDG-PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: multicentric study","author":"Lopci","year":"2010","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.beha.2011.02.005_bib55","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2967\/jnumed.108.055376","article-title":"18F-FDG PET\/CT for monitoring the response of lymphoma to radioimmunotherapy","volume":"50","author":"Jacene","year":"2009","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.beha.2011.02.005_bib56","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3324\/haematol.12253","article-title":"A prospective study of the separate predictive capabilities of 18[F]-FDG-PET and molecular response in patients with relapsed indolent non-Hodgkin\u2019s lymphoma following treatment with iodine-131-rituximab radio-immunotherapy","volume":"93","author":"Bishton","year":"2008","journal-title":"Haematologica"},{"issue":"21","key":"10.1016\/j.beha.2011.02.005_bib57","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1200\/JCO.2005.01.891","article-title":"Response assessment of aggressive non-Hodgkin\u2019s lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography","volume":"23","author":"Juweid","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2011.02.005_bib58","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1102\/1470-7330.2007.0004","article-title":"Overview of early response assessment in lymphoma with FDG-PET","volume":"7","author":"MacManus","year":"2007","journal-title":"Cancer Imaging."},{"issue":"8","key":"10.1016\/j.beha.2011.02.005_bib59","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1080\/10428190701457956","article-title":"PET for follicular lymphoma: a work in progress!","volume":"48","author":"Wirth","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"10.1016\/j.beha.2011.02.005_bib60","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s00259-007-0452-z","article-title":"Early assessment of therapy response in malignant lymphoma with the thymidine analogue [18F]FLT","volume":"34","author":"Buck","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.beha.2011.02.005_bib61","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/cbr.2010.0812","article-title":"Immuno-positron emission tomography: shedding light on clinical antibody therapy","volume":"25","author":"van Dongen","year":"2010","journal-title":"Cancer Biother Radiopharm"},{"issue":"2","key":"10.1016\/j.beha.2011.02.005_bib62","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1148\/radiology.210.2.r99fe63483","article-title":"Stages I-III follicular lymphoma: role of CT of the abdomen and pelvis in follow-up studies","volume":"210","author":"Oh","year":"1999","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.beha.2011.02.005_bib63","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2967\/jnumed.109.067892","article-title":"(18)F-FDG avidity in lymphoma readdressed: a study of 766 patients","volume":"51","author":"Weiler-Sagie","year":"2010","journal-title":"J\u00a0Nucl Med"},{"issue":"3","key":"10.1016\/j.beha.2011.02.005_bib64","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/cncr.22807","article-title":"The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification","volume":"110","author":"Tsukamoto","year":"2007","journal-title":"Cancer"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692611000120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692611000120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T22:08:40Z","timestamp":1637618920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692611000120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1521692611000120"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2011.02.005","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}